Ticker
ERNACompany Name
ERNEXA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -38.51M | -7890.57% | $ 488K |
3/31/2025 | $ -40.1M | -7495.14% | $ 535K |
12/31/2024 | $ -37.76M | -6487.46% | $ 582K |
9/30/2024 | $ -41.03M | -6862.04% | $ 598K |
6/30/2024 | $ -21.73M | -13412.35% | $ 162K |
3/31/2024 | $ -21.5M | -18698.26% | $ 115K |
12/31/2023 | $ -21.06M | -30966.18% | $ 68K |
9/30/2023 | $ -19.96M | -39143.14% | $ 51K |
6/30/2023 | $ -21.68M | 0% | $ 0 |
3/31/2023 | $ -20.57M | 0% | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for ERNEXA THERAPEUTICS INC is calculated as follows: EBIT [ $ -5.79M ] / Revenues [ $ 9.79M ]
(=) EBIT % [ -59.14% ]
Minimum
Sep 30, 2023
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.55% |
median | 9.01% |
std | 23.96% |